Skip to main content
Travis Whitfill

Travis Whitfill

Chief Operating Officer, Azitra Inc.
United States
Travis Whitfill is a serial biotech entrepreneur. He is the is the cofounder and Chief Operating Officer at Azitra. His background began in molecular biology and biochemistry after receiving scientific training at the MD Anderson Cancer Center, Duke University, and Yale University. Previously, Travis was a Partner at Bios Partners, which is biotech-focused venture capital fund. He has sat on the board of several portfolio companies, including 410 Medical, Immusoft Corporation, IN8bio (NASDAQ: IN8bio) and SIRPant Immunotherapeutics. He also is an Assistant Professor Adjunct in the Departments of Pediatrics and Emergency Medicine at Yale University. Mr. Whitfill has led numerous grant-funded projects, holds nearly a dozen patents, and has co-authored over 50 publications. He was on Forbes’ 30 under 30 list (healthcare) in 2018. Mr. Whitfill received degrees from Yale University (MPH), University College London (MPhil), Dallas Baptist University (BS), and is finishing a PhD from University College London in innovation and economics.